Geodon for the Treatment of Refractory Social Anxiety Disorder

Inclusion Criteria: * adults 18-65 years of age * primary diagnosis of SAD, using Diagnostic Standard Manual(DSM-IV) criteria * minimum Clinical Global Impression of Severity (CGI-S) score of 4 at baseline * minimum Brief Social Phobia Scale(BSPS) score of 20 at baseline * written informed consent * negative serum pregnancy test for women of childbearing potential * normal EKG Exclusion Criteria: * current DSM-IV diagnosis of bipolar disorder, schizophrenia or other psychotic disorder, mental retardation or other pervasive developmental disorder, or cognitive disorder due to a general medical condition * any current primary anxiety disorder other than SAD * current primary depression * history of substance abuse or dependence within the last 3 months * suicide risk or serious suicide attempt within the last year * clinically significant medical condition or laboratory or EKG abnormality * women of childbearing potential who are unwilling to practice an acceptable method of contraception * patients needing concurrent use of psychotropic medications * history of hypersensitivity to sertraline or ziprasidone * recent (less than 2 months) initiation of psychotherapy for SAD * history of failure to respond to augmentation with an adequate trial of an atypical antipsychotic * patients who are currently taking any of the following medications: Erythromycin, Biaxin, Avelox, Zithromax, Amantadine, Levaquin, Tamoxifen, Tegretol, Nizoral, and Levitra